Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate
Status:
Recruiting
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate if the use of Bone Morphogenic
Protein(BMP)/Demineralized Bone Matrix (DBM) versus the use of autologous Iliac Crest Bone
Graft (ICBG) will result in an increase in total cost effectiveness for patients undergoing
alveolar bone graft (ABG) for Cleft Lip and Palate (CLP) and to see if patients who are
treated with DBM/BMP will have reduced post-operative pain scores,reduced operative times,and
similar rates of bone healing compared to conventional ICBG.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston